Allogene Therapeutics Free Cash Flow (Quarterly) Insights

Allogene Therapeutics Inc (ALLO)

3.07 +0.10 (+3.37%) USD | NASDAQ | May 03, 16:00

3.065 0.00 (0.00%) Pre-Market: 20:00

Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2018. Upgrade now.

Date	Value
December 31, 2023	-53.89M
September 30, 2023	-55.54M
June 30, 2023	-62.14M
March 31, 2023	-67.67M
December 31, 2022	-63.79M
September 30, 2022	-47.88M
June 30, 2022	-43.90M
March 31, 2022	-70.14M
December 31, 2021	-46.17M
September 30, 2021	-52.22M
June 30, 2021	-52.07M
March 31, 2021	-55.79M

Date	Value
December 31, 2020	-27.38M
September 30, 2020	-57.84M
June 30, 2020	-42.78M
March 31, 2020	-53.06M
December 31, 2019	-64.38M
September 30, 2019	-50.34M
June 30, 2019	-32.75M
March 31, 2019	-40.68M
December 31, 2018	-22.80M
September 30, 2018	-18.51M
June 30, 2018	-6.583M
March 31, 2018	0.005M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

-70.14M

Minimum

Mar 2022

-27.38M

Maximum

Dec 2020

-52.62M

Average

-53.06M

Median

Mar 2020

Free Cash Flow (Quarterly) Benchmarks